Elanco Animal Health Incorporated is an animal health company focused on developing, manufacturing, and marketing products for pets and farm animals. Its portfolio includes treatments and preventive solutions for parasitic control, dermatology, pain management, vaccines, and other therapeutic areas used in companion animals and livestock. The company serves veterinarians, pet owners, farmers, and producers across a wide range of species, including dogs, cats, cattle, poultry, swine, and sheep. Elanco Animal Health Incorporated also offers products used in food-animal health and production settings, supporting disease prevention and animal wellbeing in everyday care and commercial agriculture. Headquartered in Indianapolis, Indiana, Elanco Animal Health Incorporated operates as a diversified participant in the global animal health market, with a broad product mix spanning companion animal and farm animal care.
Website450 Elanco Circle
Indianapolis, IN, 46221
United States
Elanco Animal Health (NYSE:ELAN) President and CEO Jeff Simmons outlined the company’s growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses during the Bank of America Healthcare Conference in London. Simmons said Elanco delivered 10% report
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026. Jeff Simmons, president and CEO, will participate in a fireside chat on Tuesday, September 22 at 2:10 p.m. BST (9:10 a.m. EDT).
Elanco Animal Health (ELAN) drew fresh attention after its latest closing price of US$23.17. This put recent share moves and the company’s improving annual revenue and net income figures in sharper focus for investors. Recent moves show mixed momentum for Elanco Animal Health, with a 1-day share price return of 1.36% but a 7-day share price return down 5.43%. However, the 1-year total shareholder return of 24.30% and 3-year total shareholder return of 96.36% point to a much stronger...
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
Investors talking about ELAN also mention
| # | Name | Attention |
|---|---|---|
| 1 | Zoetis Inc. Class A Common StockZTS | 0.03%+0.02 |
| 2 | IDEXX Laboratories, Inc.IDXX | 0%0 |
| 3 | PETQ - PetIQ, Inc. | —— |
| 4 | TuHURA Biosciences, Inc.HURA | 0%0 |
| 5 | OneMedNet Corp. Class A Common StockONMD | 0.02%+0.02 |
| 6 | Allied Gaming & Entertainment Inc.AGAE | 0%0 |
| 7 | Deluxe CorpDLX | 0%new |
| 8 | BHIL - Benson Hill, Inc. | —— |
| 9 | Radware Ltd.RDWR | 0%new |
| 10 | Ohmyhome Ltd. Class AOMH | 0%new |
What share of all stock conversation is about ELAN?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0% +0 | 0% +0 |
Of the messages about ELAN that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 100% +7.69 | 85.19% -7.84 | ||
| Bearish | — | — | 0% -7.69 | 14.81% +7.84 |
Of the messages about ELAN that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 64.1% | 8.59% | ||
| Technical Analysis | — | 0% | 35.9% | 1.09% | ||
| Macro | — | 0% | 0% | 1.5% | ||
| Earnings | — | 0% | 0% | 4.52% | ||
| Analysts | — | 0% | 0% | 83.72% | ||
| Controversies | — | 0% | 0% | 0.58% |
Of the messages about ELAN, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 85% | 29.17% | 8.8% | ||
| Newcomers | 100% | 15% | 70.83% | 91.2% |